stars 1 stars 2 stars 3

At AmacaThera we are the leading developer of next-generation hydrogel-based drug delivery solutions. Using our proprietary blend of known polymers, our clinically validated hydrogel platform is transforming drug delivery by enabling the precise, tunable, and sustained release of a wide range of therapeutics, from small molecules to biologics. By transforming liquid to gel at body temperature, our hydrogel enables drugs to be delivered to and stay precisely where they are needed and released over days or weeks, depending on the specific needs of each therapeutic application. Building on this foundation, we are leveraging our proprietary hydrogel platform to co-develop innovative drug delivery solutions with pharmaceutical and biotechnology partners. The platform’s inherent versatility enables the creation of long-acting formulations that enhance therapeutic efficacy, improve patient convenience, and minimize systemic exposure. Scalable and cost-effective to manufacture, our hydrogel technology supports a collaborative business model designed to deliver value across a broad range of therapeutic areas and product modalities.

AmacaThera Questions

Louis Hui is the Vice President of Business Development of AmacaThera.

9 people are employed at AmacaThera.

Top AmacaThera Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users